Join the Colorectal Cancer group to help and get support from people like you.
Colorectal Cancer News (Page 4)
Related terms: Cancer, Anal, Cancer, Colon, Cancer, Colorectal, Cancer, Rectal, Colon Cancer, Colon Carcinoma, Colorectal Carcinoma, Rectal Cancer
Cancer Vaccine Safe, Induces T-Cell Responses for KRAS-Mutated Tumors
FRIDAY, Jan. 12, 2024 – For patients with immunotherapy recalcitrant KRAS-mutated tumors, the cancer vaccine ELI-002 2P is safe and induces T-cell responses, according to a study published online...
High-Tech Screening Might Spot More Cancer Patients Who'd Benefit From Immunotherapy
FRIDAY, Dec. 29, 2023 – More patients could benefit from immunotherapy, a highly effective treatment for some cancers, new research suggests. Revising current testing guidelines so that a more...
Colon Cancer Screening May Be Even More Effective Than Experts Thought
WEDNESDAY, Dec. 27, 2023 – Getting your preventive screening colonoscopy could be even more of a lifesaver than you thought, a new analysis finds. The two gold standard tests for spotting cancers...
Beans Beneficial for Patients With History of Colorectal Neoplasia
TUESDAY, Dec. 26, 2023 – Adding a cup of beans to the usual diet enhances the gut microbiome and regulates host markers associated with metabolic obesity and colorectal cancer, according to a study...
MSI-H Colorectal Cancer Rarely Recurs After Immunotherapy Cessation
THURSDAY, Dec. 21, 2023 – Most patients with microsatellite instability-high (MSI-H) colorectal cancer do not have recurrence after cessation of immunotherapy treatment, according to a study...
Immunotherapy's Benefits for Colon Cancer Survivors Continue Long After Treatment Stops
WEDNESDAY, Dec. 20, 2023 – Many patients with advanced colon cancers who are successfully treated with immunotherapy and then stop those treatments appear to face little risk of tumor progression...
Patient Error Makes 1 in 10 Home Colon Cancer Tests Unusable
TUESDAY, Dec. 19, 2023 – At-home tests for colon cancer make this important screening readily available to folks who can’t afford or would rather not go through a colonoscopy. Unfortunately, more t...
Risk for CRC Reduced With GLP-1RAs for Drug-Naive Patients With T2D
MONDAY, Dec. 11, 2023 – For drug-naive patients with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonists (GLP-1RAs) are associated with a reduced risk for colorectal cancer (CRC)...
Less Recurrence Seen With Endoscopic Submucosal Dissection of Large Lesions
MONDAY, Dec. 11, 2023 – For patients with large benign colonic lesions, endoscopic submucosal dissection (ESD) is associated with reduced recurrence at six months compared with endoscopic mucosal...
Diabetes Meds Like Ozempic, Mounjaro Might Also Lower Risks for Colon Cancer
FRIDAY, Dec. 8, 2023 – Could blockbuster diabetes and weight-loss meds such as Ozempic, Wegovy, Mounjaro and Zepbound also lower users' odds for colon cancer? New research suggests they might. All...
Colorectal Screening Rates Do Not Differ by 10-Year Life Expectancy in Seniors
WEDNESDAY, Dec. 6, 2023 – Personalized colorectal cancer (CRC) screening based on individual life expectancy may increase the value of CRC screening programs, according to a study published online...
One Food Could Boost Health of Colon Cancer Survivors
MONDAY, Dec. 4, 2023 – Colon cancer survivors can give their health a boost by eating more navy beans, a new clinical trial finds. Small, white navy beans are full of gut-supporting fibers, amino...
Monthly News Roundup - November 2023
FDA Approves Lilly’s Zepbound for Chronic Weight Management In November, the U.S. Food and Drug Administration (FDA) approved Eli Lilly’s Zepbound (tirzepatide), a glucose-dependent insulinotropic pol...
Recent Decline in Risk for CRC Recurrence Seen in Stage I to III Disease
TUESDAY, Nov. 28, 2023 – From 2004 to 2019, the risk for recurrence of colorectal cancer (CRC) decreased in patients with stages I to III disease, according to a study published online Nov. 16 in...
>10 Percent of FIT Are Unsatisfactory and Cannot Be Processed
WEDNESDAY, Nov. 22, 2023 – More than 10 percent of fecal immunochemical tests (FIT) for colorectal cancer cannot be processed by a laboratory, and fewer than half complete a subsequent FIT within 15...
Ask a question
To post your own question to this support group, sign in or create an account.